An unprecedented Cu/Cu2O@g‐C3N4 catalysed visible light driven green synthesis of 2‐aryl‐/benzimidazoles and benzothiazoles is reported via condensation of structurally different aldehydes with o‐phenylenediamine and o‐aminothiophenol respectively. Herein, Synergistic catalysis is operating as both Cu/Cu2O@g‐C3N4 and visible‐light condition are required, no product was isolated in absence of either. Operational simplicity, ambient reaction conditions, aqueous medium, good yield of products (80–94 %) and recyclability of the catalyst without any loss in catalytic efficiency and selectivity are salient features of the envisaged protocol.
A novel approach to poly-functionalized furan synthesis is disclosed via oxidative decarboxylative [3+2] cycloaddition using co-operative catalysis by visible light and CoFe2O4 nanoparticles.
Unprecedented direct access to terminal enones via a-methylenation of aryl ketones to form C=C bond is achieved under visible-light conditions using methanol as one carbon source substrate and solvent as well. The reaction involves Cu@g-C 3 N 4catalysed in situ oxidation of methanol into formaldehyde followed by dehydrative cross aldol type reaction. Various aryl ketones react efficiently with MeOH, producing a,b-unsaturated carbonyl compounds only in 4-8 h at room temperature in excellent yield (84-97%). Operational simplicity, wide substrate scope, ambient reaction conditions, visible-light photocatalysis and novel application of MeOH as methylene donor substrate are the salient features making the envisaged protocol mild, efficient and green alternative to the existing methods for synthesis of such fine chemicals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.